Rascase Injection Substitute

Composition:
RASBURICASE-1.5MG
Uses:
<p>Rascase Injection helps remove excess uric acid levels in patients with leukaemia, lymphoma, and solid tumor malignancies. The detailed uses of Rascase Injection are as follows:</p><ul><li><strong>Management of Tumor Lysis Syndrome (TLS):</strong> Rascase Injection is used to treat elevated uric acid levels resulting from rapid tumor breakdown during chemotherapy in patients with leukemia, lymphoma, or other malignancies.</li><li><strong>Prevention of Kidney Damage in Cancer Patients:</strong> Rascase Injection helps lower uric acid concentrations in the blood, reducing the risk of acute kidney injury caused by uric acid crystallization in the renal tubules.</li><li><strong>Enzymatic Conversion of Uric Acid:</strong> Rascase Injection works by converting uric acid into allantoin, a more soluble and easily excreted compound, thereby facilitating rapid clearance from the body.</li></ul>
Medicinal Benefits:
Rascase Injection contains Rasburicase, which belongs to the recombinant urate-oxidase class of drugs. It works directly by metabolising the recombinant urate oxidase enzyme. This converts into allantoin, which is more soluble in urine. It makes it easier for the kidneys to excrete uric acid from the body.
Rascase Injection is used to help remove excess uric acid levels in patients with leukaemia, lymphoma, and solid tumour malignancies.
Rascase Injection contains Rasburicase, which works by metabolizing the recombinant urate oxidase enzyme and thus helps clear the uric acid levels.
Rascase Injection is known to cause severe hypersensitivity reactions, hemolysis, and methemoglobinemia in some patients. Hence, inform your doctor about your complete medical and medication history before starting the treatment.